Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2008
10/23/2008WO2008126772A1 Therapeutic agent for hypertension
10/23/2008WO2008126731A1 Aryl derivatives
10/23/2008WO2008125691A2 Ethers of naphtalene carboxylic acid amides as cancer cure
10/23/2008WO2008125627A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
10/23/2008WO2008125337A2 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
10/23/2008WO2008125296A1 Vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
10/23/2008WO2008107334A3 Process for the synthesis of glyt-1 inhibitors
10/23/2008WO2008101907A3 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
10/23/2008WO2008021849A3 Novel compounds as antagonists or inverse agonists at opioid receptors
10/23/2008US20080262239 Reacting amlodipine with tartaric acid in presence of dimethylformamide and cosolvent
10/23/2008US20080262238 Dendron and Dendrimer, Method of Producing the Same, and Method of Producing a Thioacetal Compound
10/23/2008US20080262237 Containing oxonol dye; controlling particle size
10/23/2008US20080262236 Process for the Preparation of 4-Carbonyl)Amino]Phenoxy}-N-Methylpyridine-2-Carboxamide
10/23/2008US20080262225 Manganese, titanium, iron, cobalt, nickel, or copper with ligand
10/23/2008US20080262224 Method of Preparation of Benzofuran-2-Carboxylic Acid -Amide
10/23/2008US20080262028 Imidazole derivatives as inhibitors of tafia
10/23/2008US20080262011 N-(2-hydroxy-1-methyl-ethyl)-3-iodobenzamide; for the treatment of a muscular disorder, a gastrointestinal disorder, or for controlling spasticity or tremors; modulates cannabinoid receptors
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261966 Bis-aryl sulfonamides
10/23/2008US20080261917 Prodrug; novel series of compounds which inhibit the MDM2-p53 interaction and have in vitro activity exerting an anti-tumour effect; cancer
10/23/2008US20080261272 reporter system reflecting the transport process that transports GPI-anchored proteins to the cell wall was constructed and compounds inhibiting this process were discovered; antifungal agents; inhibiting expression of cell wall glycoproteins and preventing pathogens from showing pathogenicity; DNA
10/23/2008DE102007018151A1 Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln New vanilloid receptor ligands and their use for the preparation of medicaments
10/23/2008CA2683049A1 Organic compounds
10/23/2008CA2681311A1 Pyridazine-, pyridine- and pyrane-derivatives as gpbar1 agonisis
10/22/2008EP1982978A1 Pyridone derivative and herbicide
10/22/2008EP1982977A1 Method for hydrolysis of heteroaromatic nitriles in aqueous fluids
10/22/2008EP1981850A2 Demethylpenclomedine analogs and their use as anticancer agents
10/22/2008EP1981849A1 Heterocyclic compounds
10/22/2008EP1981635A1 Use of metal complex compounds as oxidation catalysts
10/22/2008EP1981507A2 Potassium channel inhibitors
10/22/2008EP1981342A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
10/22/2008EP1603562A4 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
10/22/2008EP1417190B1 Substituted piperazines as modulators of the melanocortin receptor
10/22/2008CN101291926A 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases
10/22/2008CN101291916A 9-aminocarbonylsubstituted derivatives of glycylcyclines
10/22/2008CN101291910A Potassium channel inhibitors
10/22/2008CN101291908A Immunosuppressant compounds and compositions
10/22/2008CN101289422A 2,3,5,6- tetra-substituted-4-aminopyridine with sterilization and weed eradication activity and preparation
10/22/2008CN101289421A Method for synthesizing nicotinyl amino acids and sensitizing effect thereof to tumor radiotherapy
10/22/2008CN101289420A Synthetic method of nicotinic acid by using selenium dioxide as oxidizing compound
10/22/2008CN101289419A Process for preparing 2,3,5,6-tetraminopyridine hydrochloride
10/22/2008CN100427483C Anthranilic acid amide derivatives and their pharmaceutical use
10/22/2008CN100427468C Apparatus and method for separating 5-bromo-2-methyl pyridine isomer by intermittent rectification under vacuum
10/21/2008US7439535 Process for exchanging functional groups by halogen-metal exchange reaction
10/21/2008US7439393 Phenethanolamine derivatives for treatment of respiratory diseases
10/21/2008US7439368 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
10/21/2008US7439366 Phenacylamine derivatives, process for their production and pesticides containing them
10/21/2008US7439342 Thrombopoietin mimetics
10/21/2008US7439257 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
10/21/2008US7439242 PPARγ modulators
10/21/2008US7439207 2,6 substituted pyridine-3-carbonyl derivatives serving as plant protection agents having herbicidal action
10/16/2008WO2008124614A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/16/2008WO2008124610A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/16/2008WO2008124183A1 Methods of treating or preventing emesis using growth hormone secretagogues
10/16/2008WO2008124097A2 Salts of isophosphoramide mustard and analogs thereof
10/16/2008WO2008123760A1 A method for preparing a salt of ethanesulphonic acid 2 - [n-nicotinamide] and salts of said compound
10/16/2008WO2008123759A1 N-sulphoethylnicotinamide, pharmaceutical compositions containing same and use thereof for inhibiting or preventing unwanted formation of fibrous tissue
10/16/2008WO2008123758A1 Pharmaceutical composition comprising n-sulphoethylnicotinamide useful in treatment or prevention of a pulmonary disease and use of said composition for treatment or prevention of said disease
10/16/2008WO2008123469A1 Six-membered amide compound and use thereof
10/16/2008WO2008123395A1 Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient
10/16/2008WO2008123349A1 Method for producing n-phenyl-n'-phenylsulfonylpiperazine derivative
10/16/2008WO2008123207A1 Ornithine derivative
10/16/2008WO2008122787A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
10/16/2008WO2008122378A1 Novel pyridine derivatives, processes for preparing them, pharmaceutical compositions thereof
10/16/2008WO2008122329A1 Uv-filter compounds
10/16/2008WO2008057862A3 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
10/16/2008WO2008024302A3 Compounds for treating proliferative disorders
10/16/2008US20080255365 Microparticulate form of a Tetrahydropyridine derivative
10/16/2008US20080255364 Method For The Production A-Chloroalkylpyridyl Ketones And/Or The Hydrochlorides Thereof
10/16/2008US20080255329 High Activity, Low Molecular Weight Olefin Polymerization Process
10/16/2008US20080255221 Novel hydroxamates as therapeutic agents
10/16/2008US20080255214 Novel hydroxamates as therapeutic agents
10/16/2008US20080255208 2,5-di-substituted-4-pyridinyloxy-substituted-phenyl-amidine derivatives; to control the phytopathogenic fungi of plants or crops; N-Ethyl-N-methyl-N'-[4-(2-ethyl-3-chloropyridyl-4-oxy)-2,5-xylyl]form-amidine
10/16/2008US20080255202 Phenylthioacetic Acid Derivatives and Use Thereof
10/16/2008US20080255198 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator
10/16/2008US20080255197 Aminoalkylpyridines; treating HIV infections; antiinflammatory agents; rheumatic diseases; elevating progesator and stem cell count
10/16/2008US20080255189 using an thiourea compound or carbonyl thiourea compound; therapy for drug resistant infections
10/16/2008US20080255182 Certain chemical entities, compositions, and methods
10/16/2008US20080255173 Novel Specific Caspase-10 Inhibitors
10/16/2008US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread
10/16/2008US20080255166 E.g., 5-dinitro-2-dimethyldithio-carbamoyl-pyridine; strong bacteriacidal activity, especially against mycobacteria; tuberculosis and leprosy caused by mycobacteria and infectious diseases caused by staphylococci; side effect reductions; effective against drug, multidrug-resistant infections
10/16/2008US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
10/16/2008US20080255152 Diaryl ethers as opioid receptor antagonists
10/16/2008US20080255151 N-deacetylthiocolchicine deriatives, their use and pharmaceutical formulations containing them
10/16/2008US20080255144 (3'-Chloro-4-methanesulfonyl-biphenyl-2-yl)-[4-(3,4-dichloro-phenyl)-piperazin-1-yl]-methanone; neurological and neuropsychiatric disorders including schizophrenia
10/16/2008US20080255126 Inhibitors of post-proline cleaving proteases
10/16/2008US20080255124 4-[(Cyclopropylmethyl)(2-{[4-(1,1-dimethylethyl)phenyl]oxy}ethyl)amino]-2-(trifluoromethyl)benzonitrile; modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors; osteoporosis, muscle wasting,endometriosis, cardiovascular disease; breast, uterine cancer, prostatic hyperplasia
10/16/2008US20080255120 Substituted 2,5-heterocyclic derivatives
10/16/2008US20080255108 Novel thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions
10/16/2008US20080255095 Benzylamine analogues
10/16/2008US20080253974 4-methoxy-N-phenyl-N-[2-(pyridin-2-yl)ethyl]benz(enesulfon)amide and a second cooling agent, such as menthol or a derivative; similar cooling intensity to N-ethyl p-menthanecarboxamide (WS-3); ingestible or topical
10/16/2008US20080251754 Ionic onium compound with imidide; high ionic conductivity, delocalized anionic charge
10/16/2008DE102007017884A1 Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln New vanilloid receptor ligands and their use for the preparation of medicaments
10/16/2008CA2684747A1 Salts of isophosphoramide mustard and analogs thereof
10/16/2008CA2683431A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/16/2008CA2681861A1 Ornithine derivative
10/16/2008CA2680948A1 Methods of treating or preventing emesis using growth hormone secretagogues
10/16/2008CA2680838A1 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitory effect as active ingredient
10/15/2008EP1979327A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
10/15/2008EP1979326A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
1 ... 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 ... 633